SPOTLIGHT Reuters Pharma 2025: Pre-Conference Talks Featuring Nazneen RahmanByHimanshu SehgalApril 8, 20250Comments
SPOTLIGHT Reuters Pharma 2025: Pre-Conference Talks Featuring Ana CerdeiraByHimanshu SehgalApril 8, 20250Comments
News Intellia Therapeutics Reports the First Patient Dosing in P-III (MAGNITUDE-2) Trial of Nexiguran Ziclumeran for ATTRv-PNByRidhi RastogiApril 7, 20250Comments
News Ethris Partners with Lonza to Develop Intranasal Spray-Dried mRNA Vaccines Against Respiratory DiseasesByRidhi RastogiApril 7, 20250Comments
News AliveDx Seeks the US FDA’s 510(k) Clearance for MosaiQ AiPlex Connective Tissue Diseases (CTDplus) Multiplex MicroarrayByRidhi RastogiApril 7, 20250Comments
News Luye Pharma Launches Erzofri in the US for Schizophrenia and Schizoaffective DisorderByRidhi RastogiApril 7, 20250Comments
News Johnson & Johnson Reports P-IIIb (APEX) Trial Findings of Tremfya for Active Psoriatic ArthritisByRidhi RastogiApril 7, 20250Comments
News ABL Bio Licenses Grabody-B Brain Delivery Platform to GSK for ~$2.76B (£2.15B)ByRidhi RastogiApril 7, 20250Comments
